A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement.

Fountzilas, Elena

A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement. [electronic resource] - Cancer chemotherapy and pharmacology 11 2018 - 877-885 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1432-0843

10.1007/s00280-018-3680-y doi


Administration, Oral
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Bevacizumab--administration & dosage
Capecitabine--administration & dosage
Female
Hepatic Artery
Humans
Infusions, Intra-Arterial
Injections, Intravenous
Liver Neoplasms--drug therapy
Male
Maximum Tolerated Dose
Middle Aged
Neoplasm Invasiveness
Oxaliplatin--administration & dosage
Treatment Outcome